Evidence map›Paper›PMID 33053160›Full record

ArticleCardiovascular research2021

High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension.

Giacomo Rossitto, Giuseppe Maiolino, Silvia Lerco, Giulio Ceolotto, Gavin Blackburn, Sheon Mary, Giorgia Antonelli, Chiara Berton, Valeria Bisogni, Maurizio Cesari and 11 more

Abstract read
In one paragraph

Article in Cardiovascular research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Salt and chronic kidney disease.Nature reviews. Nephrology · 2026
    Review
  6. Water intake mediates cross-sectional associations between urinary kidney injury biomarkers and race in emerging adults.American journal of physiology. Regulatory, integrative and comparative physiology · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Giacomo RossittoInstitute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre 126 University Place, University of Glasgow, Glasgow G12 8TA, UK.
Giuseppe MaiolinoClinica dell'Ipertensione, DIMED, University of Padua, University Hospital, via Giustiniani 2, Padua 35126, Italy.
Silvia LercoClinica dell'Ipertensione, DIMED, University of Padua, University Hospital, via Giustiniani 2, Padua 35126, Italy.
Giulio CeolottoClinica dell'Ipertensione, DIMED, University of Padua, University Hospital, via Giustiniani 2, Padua 35126, Italy.
Gavin BlackburnGlasgow Polyomics, University of Glasgow, Wolfson Wohl Cancer Research Centre, Garscube Campus, Bearsden, Glasgow G61 1BD, UK.
Sheon MaryInstitute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre 126 University Place, University of Glasgow, Glasgow G12 8TA, UK.
Giorgia AntonelliLaboratory Medicine, DIMED, University of Padua, University Hospital, via Giustiniani 2, Padua 35126, Italy.
Chiara BertonClinica dell'Ipertensione, DIMED, University of Padua, University Hospital, via Giustiniani 2, Padua 35126, Italy.
Valeria BisogniClinica dell'Ipertensione, DIMED, University of Padua, University Hospital, via Giustiniani 2, Padua 35126, Italy.
Maurizio CesariClinica dell'Ipertensione, DIMED, University of Padua, University Hospital, via Giustiniani 2, Padua 35126, Italy.
Teresa Maria SecciaClinica dell'Ipertensione, DIMED, University of Padua, University Hospital, via Giustiniani 2, Padua 35126, Italy.
Livia LenziniClinica dell'Ipertensione, DIMED, University of Padua, University Hospital, via Giustiniani 2, Padua 35126, Italy.
Alessio PinatoLaboratory Medicine, DIMED, University of Padua, University Hospital, via Giustiniani 2, Padua 35126, Italy.
Augusto MontezanoInstitute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre 126 University Place, University of Glasgow, Glasgow G12 8TA, UK.
Rhian M TouyzInstitute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre 126 University Place, University of Glasgow, Glasgow G12 8TA, UK.
Mark C PetrieInstitute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre 126 University Place, University of Glasgow, Glasgow G12 8TA, UK.
Ronan DalyGlasgow Polyomics, University of Glasgow, Wolfson Wohl Cancer Research Centre, Garscube Campus, Bearsden, Glasgow G61 1BD, UK.
Paul WelshInstitute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre 126 University Place, University of Glasgow, Glasgow G12 8TA, UK.
Mario PlebaniLaboratory Medicine, DIMED, University of Padua, University Hospital, via Giustiniani 2, Padua 35126, Italy.
Gian Paolo RossiClinica dell'Ipertensione, DIMED, University of Padua, University Hospital, via Giustiniani 2, Padua 35126, Italy.
Christian DellesInstitute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre 126 University Place, University of Glasgow, Glasgow G12 8TA, UK.

Funding

British Heart Foundation RE/13/5/30177British Heart Foundation RE/18/6/34217Wellcome TrustWellcome Trust 204820/Z/16/Z
6 · The paper itself

Abstract

aimsA blood pressure (BP)-independent metabolic shift towards a catabolic state upon high sodium (Na+) diet, ultimately favouring body fluid preservation, has recently been described in pre-clinical controlled settings. We sought to investigate the real-life impact of high Na+ intake on measures of renal Na+/water handling and metabolic signatures, as surrogates for cardiovascular risk, in hypertensive patients. METHODS AND

resultsWe analysed clinical and biochemical data from 766 consecutive patients with essential hypertension, collected at the time of screening for secondary causes. The systematic screening protocol included 24 h urine (24 h-u-) collection on usual diet and avoidance of renin-angiotensin-aldosterone system-confounding medications. Urinary 24 h-Na+ excretion, used to define classes of Na+ intake (low ≤2.3 g/day; medium 2.3-5 g/day; high >5 g/day), was an independent predictor of glomerular filtration rate after correction for age, sex, BP, BMI, aldosterone, and potassium excretion [P = 0.001; low: 94.1 (69.9-118.8) vs. high: 127.5 (108.3-147.8) mL/min/1.73 m2]. Renal Na+ and water handling diverged, with higher fractional excretion of Na+ and lower fractional excretion of water in those with evidence of high Na+ intake [FENa: low 0.39% (0.30-0.47) vs. high 0.81% (0.73-0.98), P < 0.001; FEwater: low 1.13% (0.73-1.72) vs. high 0.89% (0.69-1.12), P = 0.015]. Despite higher FENa, these patients showed higher absolute 24 h Na+ reabsorption and higher associated tubular energy expenditure, estimated by tubular Na+/ATP stoichiometry, accordingly [Δhigh-low = 18 (12-24) kcal/day, P < 0.001]. At non-targeted liquid chromatography/mass spectrometry plasma metabolomics in an unselected subcohort (n = 67), metabolites which were more abundant in high versus low Na+ intake (P < 0.05) mostly entailed intermediates or end products of protein catabolism/urea cycle.

conclusionWhen exposed to high Na+ intake, kidneys dissociate Na+ and water handling. In hypertensive patients, this comes at the cost of higher glomerular filtration rate, increased tubular energy expenditure, and protein catabolism from endogenous (muscle) or excess exogenous (dietary) sources. Glomerular hyperfiltration and the metabolic shift may have broad implications on global cardiovascular risk independent of BP.

Indexed as

Blood PressureGlomerular Filtration RateMetabolomeAdultBiomarkersDietary ProteinsEssential HypertensionFemaleFluid ShiftsHumansKidneyMaleMetabolomicsMiddle AgedMuscle ProteinsNatriuresisBiomarkersDietary ProteinsMuscle ProteinsSodium, DietaryGlomerular hyperfiltrationHypertensionKidneyMetabolismSalt

Identifiers

PMID33053160
PMCPMC8064429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.